Related Experiment Video
Updated: May 17, 2026

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
Phosphoinositides and cardiovascular diseases
Alessandra Ghigo1, Alessia Perino, Emilio Hirsch
1Department of Genetics, Biology and Biochemistry, University of Torino, Molecular Biotechnology Center, Italy.
Phosphoinositides (PIs) regulate cellular functions and are linked to cardiovascular diseases. This review details how major cardiovascular PIs contribute to atherosclerosis, heart failure, and arrhythmias.
Area of Science:
- Biochemistry
- Cell Biology
- Cardiovascular Medicine
Background:
- Phosphoinositides (PIs) are critical lipid mediators derived from phosphatidylinositol.
- PI signaling pathways are implicated in numerous cellular processes.
- Emerging evidence links PI signaling to the development of human diseases, particularly cardiovascular conditions.
Purpose of the Study:
- To provide a comprehensive overview of the roles of major cardiovascular phosphoinositides.
- To elucidate the specific functions of PIs in the pathogenesis of key cardiovascular diseases.
- To highlight the involvement of PI-mediated pathways in atherosclerosis, heart failure, and arrhythmias.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of studies investigating PI metabolism and signaling.
- Focus on cardiovascular pathologies including atherosclerosis, heart failure, and arrhythmias.
Main Results:
- Phosphoinositides play diverse and crucial roles in cardiovascular cell function.
- Specific PIs are differentially involved in the progression of atherosclerosis.
- Dysregulation of PIs contributes to the development and exacerbation of heart failure and arrhythmias.
Conclusions:
- Cardiovascular phosphoinositides are key regulators in maintaining cardiac health.
- Understanding PI functions offers insights into novel therapeutic strategies for cardiovascular diseases.
- Targeting PI pathways may hold promise for treating atherosclerosis, heart failure, and arrhythmias.
More Related Videos
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Second Messengers